Table 2.
T-B-NK+ (n = 5) | T + B-NK+ (n = 4) | T + B + NK+ (n = 2) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Other phenotype n(2) | Omenn n(2) | ||||||||||
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 | Patient 11 | |
IgG (mg/dl) | 371 | 546 | 546 | 517 | 312 | 1372 | 1840 | 1080 | 662 | 159 | 1590 |
IgA (mg/dl) | < 6 | < 6 | < 6 | < 6 | < 6 | 22 | 219 | 49 | < 6 | 8 | 52 |
IgM (mg/dl) | < 17 | < 17 | < 17 | < 17 | < 17 | 222 | 120 | 179 | < 17 | 52 | 75 |
WBC | 7800 | 8220 | 532 | 8280 | 6780 | 5900 | 8740 | 24700 | 19200 | 15500 | 11000 |
Abs.lymp h./mm3 | 1028 | 657 | 180 | 3120 | 650 | 3835 | 1748 | 9386 | 6144 | 7630 | 5500 |
CD3+ % | 10 | 0 | 0 | 0 | 0 | 56 | 78 | 92 | 78 | 59 | 51 |
CD3 + CD 4+ % | 0 | 0 | 0 | 0 | 0 | 11 | 17 | 19 | 33 | 37 | 9 |
CD3 + CD 8+ % | 10 | 0 | 0 | 0 | 0 | 50 | 55 | 60 | 47 | 19 | 39 |
CD19+ % | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 30 | 36 |
NK + % CD16 + 56+) | 75 | 43 | 90 | 78 | 63 | 43 | 12 | 2 | 11 | 7 | 16 |
HLA DR + T cell % | 10 | 58 | 0 | 0 | 0 | 45 | 67 | 85 | 73 | 12 | 37 |
Molecular analyses | p.R394Q/p.R394Q homozy. mutation | p.R394Q/p.R394Q homozy. mutation | p.R776Q, 3047-3049 del GCC | p.H249R (homozy) mutation? Polymorphism? | p.R394Q/p.R394Q homozy. mutation | p.H249R/p.K820R (compound heterozy.) mutation? Polymorphism? | p.H249R/p.K820R (compound heterozy) mutation? Polymorphism? | p.H249R (heterozy) mutation? Disease causing? Polymorphism? | p.Q248X/p.Q248X homozy. mutation | p.H249R (heterozy) mutation? Disease causing? Polymorphism? | P85fs32 × = del A256/A257 |
The most common symptoms were pneumonia (n = 10), chronic diarrhea (n = 6), infections plus dermatitis (n = 3), infections plus moniliasis (n = 3) or all of these (n = 3). The respiratory tract diseases were the most frequent infection type. Lymphadenopathy and hepatosplenomegaly were observed in 36% and 90% of RAGD patients, respectively. Auotoimmunity was recorded in three patients. CMV infection was detected in two patients with T + B + NK + phenotype.